SI2061513T1 - Postopek zdravljenja pacientov s hepatitisom c - Google Patents

Postopek zdravljenja pacientov s hepatitisom c

Info

Publication number
SI2061513T1
SI2061513T1 SI200830406T SI200830406T SI2061513T1 SI 2061513 T1 SI2061513 T1 SI 2061513T1 SI 200830406 T SI200830406 T SI 200830406T SI 200830406 T SI200830406 T SI 200830406T SI 2061513 T1 SI2061513 T1 SI 2061513T1
Authority
SI
Slovenia
Prior art keywords
patients
treating hepatitis
hepatitis
relapsed
infection
Prior art date
Application number
SI200830406T
Other languages
English (en)
Inventor
Janice K Albrecht
Clifford A Brass
Robert Orville Ii Ralston
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40262964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2061513(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of SI2061513T1 publication Critical patent/SI2061513T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
SI200830406T 2007-09-14 2008-09-11 Postopek zdravljenja pacientov s hepatitisom c SI2061513T1 (sl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US99375307P 2007-09-14 2007-09-14
US99876207P 2007-10-12 2007-10-12
US149407P 2007-10-30 2007-10-30
PCT/US2008/010626 WO2009038663A1 (en) 2007-09-14 2008-09-11 Method of treating hepatitis c patients
EP08831728A EP2061513B1 (en) 2007-09-14 2008-09-11 Method of treating hepatitis c patients

Publications (1)

Publication Number Publication Date
SI2061513T1 true SI2061513T1 (sl) 2011-11-30

Family

ID=40262964

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200830406T SI2061513T1 (sl) 2007-09-14 2008-09-11 Postopek zdravljenja pacientov s hepatitisom c

Country Status (18)

Country Link
US (1) US20100226885A1 (sl)
EP (2) EP2489369A1 (sl)
JP (1) JP2010539165A (sl)
CN (1) CN101883590A (sl)
AT (1) ATE519503T1 (sl)
AU (1) AU2008301981A1 (sl)
CA (1) CA2699280A1 (sl)
CY (1) CY1112116T1 (sl)
DK (1) DK2061513T3 (sl)
ES (1) ES2369321T3 (sl)
HK (1) HK1129315A1 (sl)
HR (1) HRP20110637T1 (sl)
MX (1) MX2010002909A (sl)
NZ (1) NZ583825A (sl)
PL (1) PL2061513T3 (sl)
PT (1) PT2061513E (sl)
SI (1) SI2061513T1 (sl)
WO (1) WO2009038663A1 (sl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201242974A (en) 2010-11-30 2012-11-01 Gilead Pharmasset Llc Compounds
WO2012151283A1 (en) * 2011-05-04 2012-11-08 Merck Sharp & Dohme Corp. Drug substances, pharmeceutical compositions and methods for preparing the same
LT2709613T (lt) 2011-09-16 2018-02-12 Gilead Pharmasset Llc Žmogaus hepatito viruso (hcv) gydymo būdai
DK2583677T1 (da) 2011-10-21 2015-01-19 Abbvie Inc Fremgangsmåder til behandling af HCV omfattende mindst to direktevirkende antivirale midler, ribavirin, men ikke inteferon
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
TW201600087A (zh) 2011-10-21 2016-01-01 艾伯維有限公司 治療ｃ型肝炎病毒（ｈｃｖ）的方法
JP2014532657A (ja) 2011-10-31 2014-12-08 ギリアド ファーマセット エルエルシー Ｃ型肝炎ウイルスを処置するための方法および組成物
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
MX2014006373A (es) 2011-11-29 2014-07-22 Gilead Pharmasset Llc Composiciones y metodos para tratar el virus de la hepatitis c.
CA2863645A1 (en) 2012-02-01 2013-08-08 Samuel Waksal Once daily treatment of hepatitis c with ribavirin and taribavirin
PE20151778A1 (es) 2013-01-31 2015-12-16 Gilead Pharmasset Llc Formulacion combinada de dos compuestos antivirales
JP7129703B2 (ja) 2016-04-28 2022-09-02 エモリー ユニバーシティー アルキン含有ヌクレオチド及びヌクレオシド治療組成物並びにそれらに関連した使用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003507322A (ja) * 1998-12-18 2003-02-25 シェリング・コーポレーション リバビリン−ＰＥＧ化インターフェロン−α誘発ＨＣＶ併用治療
US6824768B2 (en) * 1998-12-18 2004-11-30 Schering Corporation Ribavirin-pegylated interferon alfa induction HCV combination therapy
AR029337A1 (es) * 1999-03-02 2003-06-25 Schering Corp Uso de interferon alfa pegilado para la preparacion de un medicamento para la terapia contra el hiv
KR100904788B1 (ko) * 2000-07-21 2009-06-25 쉐링 코포레이션 Ｃ형 간염 바이러스의 ｎｓ3-세린 프로테아제억제제로서의 신규한 펩티드
SV2003000617A (es) 2000-08-31 2003-01-13 Lilly Co Eli Inhibidores de la proteasa peptidomimetica ref. x-14912m
PT1730110E (pt) 2004-02-27 2010-09-14 Schering Corp Compostos de enxofre como inibidores de serina-protease ns3 do vírus da hepatite c
WO2006016930A2 (en) * 2004-05-14 2006-02-16 Intermune, Inc. Methods for treating hcv infection
US20070004635A1 (en) * 2005-06-02 2007-01-04 Schering Corporation Method of treating interferon non-responders using HCV protease inhibitor
PE20080197A1 (es) * 2006-02-09 2008-04-11 Schering Corp Combinaciones que involucran el (los) inhibidor (es) de la proteasa del hcv, y metodos de tratamiento relacionado al (los) mismos(s)
CN102083435A (zh) * 2008-06-10 2011-06-01 詹森药业有限公司 特拉匹韦给药方案

Also Published As

Publication number Publication date
MX2010002909A (es) 2010-03-30
WO2009038663A1 (en) 2009-03-26
CA2699280A1 (en) 2009-03-26
EP2061513B1 (en) 2011-08-10
EP2061513A1 (en) 2009-05-27
PT2061513E (pt) 2011-10-17
DK2061513T3 (da) 2011-11-21
PL2061513T3 (pl) 2011-12-30
HRP20110637T1 (hr) 2011-10-31
JP2010539165A (ja) 2010-12-16
CY1112116T1 (el) 2015-11-04
NZ583825A (en) 2012-06-29
ATE519503T1 (de) 2011-08-15
EP2489369A1 (en) 2012-08-22
CN101883590A (zh) 2010-11-10
AU2008301981A1 (en) 2009-03-26
ES2369321T3 (es) 2011-11-29
US20100226885A1 (en) 2010-09-09
HK1129315A1 (en) 2009-11-27

Similar Documents

Publication Publication Date Title
HK1129315A1 (en) Method of treating hepatitis c patients
PL2219642T3 (pl) Komponent sylibininy do leczenia zapalenia wątroby
MY144318A (en) Methods of treating hiv infection.
ZA200804550B (en) Methods, compositions, and kits for the treatment of medical conditions
EP1753777A4 (en) METHOD AND COMPOSITIONS FOR TREATING AND PREVENTING HIV INFECTION WITH TRIM5a
TN2010000137A1 (en) Spiropyrrolidines and their use against hcv and hiv infection
HK1096320A1 (en) Apheresis device
PL1799231T3 (pl) Zastosowanie cyklodekstryny do leczenia i zapobiegania chorobom zapalnym oskrzeli
MY177001A (en) Phenothiazine compounds for treating mild cognitive impairment
TW200731984A (en) C3-convertase inhibitors for the prevention and treatment of age-related macular degeneration in patients with at risk variants of complement factor H
TN2009000211A1 (en) Antiviral composition and method of use
UA88655C2 (ru) S-миртазапин для лечения прилива крови
PL383722A1 (pl) Sposoby i materiały z trans-klomifenem do leczenia bezpłodności u mężczyzn
BRPI0417108A (pt) métodos de tratamento de rejeições de transplantes em pacientes
WO2004004653A3 (en) Methods for treating psychosis associated with interferon-alpha therapy
WO2009033183A3 (en) Compounds and methods for treatment of hcv and conditions associated with cd81 binding
HK1097247A1 (en) Process for the treatment of sludge
GB0415181D0 (en) Compounds for use in the treatment of infection
IL187160A0 (en) Compositions and methods for treating hiv infection with cupredoxin and cytochrome c
DE112006001557A5 (de) Verfahren zur Abformung des Kiefers bzw. der Kiefersituation bei der zahnmedizinischen Behandlung von Patienten
MY166063A (en) Intravenous antiviral treatments
GB0509911D0 (en) Medical treatment aid for use in treating children
EP1879519A4 (en) IMPLANTABLE SLINGS FOR TREATING INCONTINENCE AND USE METHOD THEREFOR
FI20085282A0 (fi) Biotekninen prosessi rautaa sisältävien mineraalien, konsentraattien, steriilien prosessivesien ja yhdisteiden käsittelemiseksi
IL187889A0 (en) Compositions and methods for preventing or treating hiv infection